Welcome to our dedicated page for RTX SEC filings (Ticker: RTX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
From Collins Aerospace avionics to Pratt & Whitney geared-turbofan engines and Raytheon missile systems, RTX’s business spans commercial aviation and defense—making its disclosures rich with backlog figures, classified program notes, and multi-year engine guarantees. If you have ever tried to locate segment margins or follow contract revenue inside an RTX annual report, you know the challenge.
Stock Titan turns that complexity into clarity. Our AI-powered summaries flag risk factors, outline R&D by program, and translate pension footnotes into plain English. Need the latest RTX quarterly earnings report 10-Q filing? It appears the moment EDGAR posts, paired with trend charts. Curious about RTX insider trading Form 4 transactions? Get real-time alerts the instant an executive files. We also surface every RTX 8-K material events explained entry, so supply-chain updates or missile test results never slip past you—consider it RTX SEC filings explained simply.
Dive deeper by form: the RTX annual report 10-K simplified highlights Collins Aerospace aftermarket sales; our RTX earnings report filing analysis tracks engine delivery volumes; the RTX proxy statement executive compensation section shows how performance stock units align with free-cash-flow targets. Whether you’re monitoring RTX executive stock transactions Form 4, seeking RTX Form 4 insider transactions real-time, or understanding RTX SEC documents with AI before the market reacts, every filing is searchable, summarized, and updated continuously. Save hours, spot trends, and act with confidence—Stock Titan delivers the insights investors need, quickly and clearly.
Northern Trust Corporation filed an 8-K to disclose that on 28 July 2025 its Board of Directors approved a new common-stock repurchase authorization of up to $2.5 billion. The program permits – but does not obligate – the company to buy back outstanding NTRS shares from time to time; it carries no expiration date. No other material transactions, financial results or operational updates were included in this report. The filing also lists a related press release (Exhibit 99.1) and standard Inline XBRL cover-page information.
IQVIA Holdings Inc. (IQV) – Form 4 insider transaction
Executive Vice President & General Counsel Eric Sherbet exercised 11,870 Stock Appreciation Rights (SARs) at an exercise price of $97.20 on 07/23/2025, converting them into an equal number of common shares.
Immediately after the exercise, Sherbet:
- Sold 5,800 shares at a weighted-average $190.05 (range $189.99–$190.18), generating roughly $1.1 million in gross proceeds.
- Disposed of 6,070 shares at $190.10, likely for tax-withholding.
Following the transactions, Sherbet’s direct ownership decreased to 21,108 common shares; all SARs from the 03/01/2021 grant are now fully exercised, leaving zero derivative securities outstanding.
The activity represents a net sale of the entire 11,870 shares obtained through exercise, with no new open-market purchases. While the executive retains a meaningful equity stake (≈$4.0 million at $190), the sale may signal profit-taking rather than incremental confidence.
RTX Corporation – Form 144 notice
The filer intends to sell up to 8,704 RTX common shares on the NYSE through UBS Financial Services around 24 Jul 2025. At the reference price the stake is worth roughly $1.36 million and equals only about 0.00065 % of the 1,338,541,827 shares outstanding. The stock was obtained via RSU grants dated 13 Feb 2018 (3,000 sh), 30 Jan 2022 (4,737 sh) and 8 Feb 2024 (967 sh), each paid for by wire transfer. The filer states no sales occurred in the prior three months and certifies possession of no undisclosed material adverse information, meeting Rule 144 requirements.
This Form 144 filing discloses that an unidentified insider plans to sell 1,462 RTX Corporation common shares through UBS Financial Services on or about 23 July 2025. The shares stem from RSU vesting on 15 Feb 2025. Estimated aggregate market value of the planned sale is $222,595, versus ≈1.34 billion total shares outstanding. No prior insider sales were reported in the last three months, and the filer attests to possessing no undisclosed adverse information. No additional financial data, performance metrics or company-level developments are included.